 | Up a level |
Meijer, A J M; Diepstraten, F A; Langer, T; Broer, L; Domingo, I K; Clemens, E; Uitterlinden, A G; de Vries, A C H; van Grotel, M; Vermeij, W P; Ozinga, R A; Binder, H; Byrne, J; van Dulmen-den Broeder, E; Garrè, M L; Grabow, D; Kaatsch, P; Kaiser, M; Kenborg, L; Winther, J F; ... (2021). TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study. NPJ precision oncology, 5(1), p. 64. Springer Nature 10.1038/s41698-021-00178-z
Sistonen, J; Madadi, P; Ross, C J; Yazdanpanah, M; Lee, J W; Landsmeer, M L A; Nauta, M; Carleton, B C; Koren, G; Hayden, M R (2012). Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers. Clinical pharmacology & therapeutics, 91(4), pp. 692-9. New York, N.Y.: Nature Publishing Group 10.1038/clpt.2011.280
